Immunological response to hepatitis B vaccination in patients with AIDS and virological response to highly active antiretroviral therapy

Scandinavian Journal of Infectious Diseases

Volumn 40, Issue 1, 2008, Pages 54-58

  Paitoonpong, Leilani ^a   Suankratay, Chusana ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; HEPATITIS B ANTIBODY; NEVIRAPINE; PROTEINASE INHIBITOR; RECOMBINANT HEPATITIS B VACCINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG RESPONSE; FEMALE; HEPATITIS B; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INJECTION SITE REACTION; MALE; MYALGIA; PATIENT COMPLIANCE; SEROCONVERSION; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; VACCINATION; VIRUS IMMUNITY; VIRUS LOAD;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HIV INFECTIONS; HUMANS; MALE; PROSPECTIVE STUDIES;

EID: 37749043357     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.1080/00365540701522975     Document Type: Article

References (29)

1. Kellerman, SE, Hanson, DL, McNaghten, D. and Fleming, PL. (2004) Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. Clin Infect Dis, 188, pp. 571-577.
2. Gilson, RJC, Hawkins, AE, Beecham, MR, Ross, E., Waite, J. and Briggs, M. (1997) Interactions between HIV and hepatitis B virus in homosexual men: Effects on the natural history of infection. AIDS, 11, pp. 597-606.
3. Colin, JF, Hatem, DC, Loriot, MA, Peignoux, MM, Phan, BN and Auperin, A. (1999) Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology, 29, pp. 1306-1310.
4. Hadler, SC, Judson, FN and O'Malley, PM. (1991) Outcome of hepatitis B virus infection in homosexual men and its relation to prior human immunodefiency virus infection. J Infect Dis, 163, pp. 454-459.
5. Bodsworth, NJ, Cooper, DA and Donovan, B. (1991) The influence of human immunodefiency type 1 infection on the development of the hepatitis B carrier state. J Infect Dis, 163, pp. 1138-1140.
6. Thio, CL, Seaberg, EC and Skolasky, R. (2002) HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS). Lancet, 360, pp. 1921-1926.
7. Rousseau, MC, Moreau, J. and Delmont, J. (2000) Vaccination and HIV: A review of the literature. Vaccine, 18, pp. 825-831.
8. Carne, CA, Weller, IVD, Waite, J., Briggs, M., Pearce, F. and Adler, MW (1987) Impaired responsiveness of homosexual men with HIV antibodies to plasma derived hepatitis B vaccine. Br Med J, 294, pp. 866-868.
9. Collier, AC, Corey, L., Murphy, VL and Handsfield, HH. (1988) Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination. Ann Intern Med, 109, pp. 101-105.
10. Odaka, N., Elderd, L., Cohn, S., Munoz, A., Fields, HA and Fox, R. (1988) Comparative immunogenicity of plasma and recombinant hepatitis B vaccines in homosexual men. JAMA, 260, pp. 3245-3260.
11. Mannucci, PM, Zanetti, AR, Gringeri, A., Tanzi, E., Morfini, M. and Messori, A. (1989) Long-term immunogenicity of a plasma-derived hepatitis B vaccine in HIV seropositive and HIV seronegative haemophiliacs. Arch Intern Med, 149, pp. 1333-1337.
12. Loke, RH, Murray-Lyon, IM, Coleman, JC, Evans, BA and Zuckerman, AJ. (1990) Diminished response to recombinant hepatitis B vaccine in homosexual men with HIV antibody: An indicator of poor prognosis. J Med Virol, 31, pp. 109-111.
13. Bruguera, M., Cremades, M., Salinas, R., Costa, J., Grau, M. and Sans, J. (1992) Impaired response to recombinant hepatitis B vaccine in HIV-infected persons. J Clin Gastroenterol, 14, pp. 27-30.
14. Keet, IPM, van Doornum, G., Safary, A. and Countinho, RA. (1992) Insufficient response to hepatitis B vaccination in HIV positive homosexual men. AIDS, 6, pp. 509-510.
15. Tayal, SC and Sankar, KN. (1994) Impaired response to recombinant hepatitis B vaccine in asymptomatic HIV-infected individuals. AIDS, 8, pp. 558-559.
16. Lederman, MM. (2001) Immune restoration and CD4+ T-cell function with antiretroviral therapies. AIDS, 15, p. S11.
17. Overton, ET, Sungkanupargh, S., Powderly, WG, Seyfried, W., Groger, RK and Aberg, JA. (2005) Undetectable plasma HIV RNA load predicts success after hepatitis B vaccination in HIV-infected persons. Clin Infect Dis, 41, pp. 1045-1048.
18. Veiga, AP, Casseb, J. and Duarte, AJ. (2006) Humoral response to hepatitis B vaccination and its relationship with T CD45RA+ (naive) and CD45RO+ (memory) subsets in HIV-1-infected subjects. Vaccine, 24, pp. 7124-7128.
19. Bene, MC, Sarda, MN Kolopp, Kaissouni, J El, Kennel, A De March, Mole, C. and Kohler, C. (1998) Automated cell count in flow cytometry: A valuable tool to assess CD4 absolute levels in peripheral blood. Am J Clin Pathol, 110, pp. 321-326.
20. Ganem, D. and Schneider, R. (2001) Hepatitis B and hepatitis delta virus. Fields virology, pp. 2043-2094. Lippincott, Philadelphia
21. Fonseca, MO, Pang, LW, Cavalheiro, NP, Barone, AA and Lopes, MH. (2005) Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose. Vaccine, 23, pp. 2902-2908.
22. Valdez, H., Smith, KY, Landay, A., Connick, E., Kuritzkes, DR and Kessler, H. (2000) Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen. ACTG 375 team. AIDS Clinical Trials Group. AIDS, 14, pp. 11-21.
23. Sasaki, MGM, Mello, RS, Siciliano, RF and Wang, L. (1998) Response of HIV/AIDS patients to hepatitis B recombinant vaccine. Brazil J Infect Dis, 2, pp. 236-240.
24. Rey, D., Krantz, V., Partisani, M., Schmitt, MP, Meyer, P. and Libbrecht, E. (2000) Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load. Vaccine, 18, pp. 1161-1165.
25. Wong, EK, Bodsworth, NJ, Slade, MA, Mulhall, BP and Donovan, B. (1996) Response to hepatitis B vaccination in a primary care setting: Influence of HIV infection, CD4+ lymphocyte count and vaccination schedule. Int J STD AIDS, 7, pp. 490-494.
26. Keating, GM and Noble, S. (2003) Recombinant hepatitis B vaccine (Engerix-B®). A review of its immunogenicity and protective efficacy against hepatitis B. Drugs, 63, pp. 1021-1051.
27. Poland, GA and Jacobson, RM. (2004) Prevention of hepatitis B with the hepatitis B vaccine. N Engl J Med, 351, pp. 2832-2838.
28. Crovari, P., Crovari, PC, Petrilli, RC, Icardi, GC and Bonanni, P. (1987) Immunogenicity of a yeast-derived hepatitis B vaccine (Engerix-B®) in healthy young adults. Postgrad Med J, 63, pp. 161-164.
29. Tedaldi, EM, Baker, RK, Moorman, AC, Wood, KC, Fuhrer, J. and McCabe, RE (2004) Hepatitis A and B vaccination practices for ambulatory patients infected with HIV. Clin Infect Dis, 38, pp. 1478-1484.